Sign inGet started

ARTV

Artiva Biotherapeutics, Inc.CIK 1817241 ☆ Sign in to watchCongress trades
Open-mkt buys · 90d
—
0 trades · 0 insiders
Open-mkt sales · 90d
$3.27M
19 trades · 4 insiders
Net · 90d
$-3.27M
Insiders on file
27

AI insights for ARTV PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
AI insights for ARTV
Insider sentiment score with a plain-English explanation, conviction score on every buy, and how the stock performed 30 and 90 days after past insider buys.
Upgrade to Pro · $99/yearAlready Pro? Log in

Daily buy vs sell · 90 days

$1.82M2026-08-18 buys — 2026-08-18 sales $10.3K08-182026-08-27 buys — 2026-08-27 sales $197.5K08-272026-09-03 buys — 2026-09-03 sales $1.82M09-032026-09-08 buys — 2026-09-08 sales $511.6K09-082026-10-05 buys — 2026-10-05 sales $557.3K10-052026-10-06 buys — 2026-10-06 sales $168.9K10-06
■ Open-market buys (P)   ■ Open-market sales (S) · daily dollar value by transaction date

Insiders

InsiderRoleTradesBoughtSoldLast trade
Aslan FredPresident and CEO34$0$2.99M2026-10-06
Banerjee SubhashisChief Medical Officer23$0$303.2K2026-10-05
Horan ChristopherChief Tech Operations Officer19$0$365.1K2026-10-05
Bush JenniferCOO, CLO, Secy, Compliance Off20$0$323.7K2026-10-05
Baker Daniel G.Director6$0$02026-09-10
Stoppel LauraDirector5$0$02026-09-10
Sorg Elaine K.Director5$0$02026-09-10
MOORE ALISONDirector6$0$02026-09-10
DANIELS BRIANDirector5$0$02026-09-10
Kolchinsky PeterDirector, 10% Owner20$107.18M$02026-09-10
RA CAPITAL MANAGEMENT, L.P.Director, 10% Owner8$1.16M$02026-09-10
HOUGEN ELIZABETH LDirector5$0$02026-09-10
Miralles Gines DiegoPresident & Head of R&D7$0$02026-09-09
RA Capital Healthcare Fund LPDirector, 10% Owner4$1.89M$02026-07-31
RA Capital Nexus Fund III, L.P.Director3$100.41M$02026-07-24
RA Capital Nexus Fund, L.P.Director4$7.71M$02026-07-13
Shah Rajeev M.Director, 10% Owner2$194.0K$02026-07-13
Raymon HeatherSVP, Research and Development14$0$27.9K2026-05-19
GC Corp.10% Owner2$16.50M$02026-05-11
Huston Thad AllenChief Financial Officer1$0$02026-03-10
Krishnamohan NehaChief Financial Officer5$0$02025-11-15
Graef ThorstenChief Medical Officer2$0$02025-02-26
GC Cell Corp10% Owner12$25.00M$02024-07-22
Huh Yong-JunDirector12$25.00M$02024-07-22
VENBIO GLOBAL STRATEGIC GP III, LTD10% Owner6$5.00M$02024-07-22
5AM Partners VI, LLC10% Owner6$10.00M$02024-07-22
Wellington Biomedical Innovation Master Investors (Cayman) I L.P.10% Owner3$0$02024-07-22

Trade history

InsiderRoleCodeTradeFiledSharesPriceValueOwned after
Aslan FredChief Executive Officer, Dir S Sale2026-10-062026-10-0723,463$7.20 $168.9K1,519,606SEC↗
Horan ChristopherChief Tech Operations Office S Sale2026-10-052026-10-0610,340$6.84 $70.7K312,744SEC↗
Bush JenniferCOO, CLO, Compliance Officer S Sale2026-10-052026-10-068,370$6.84 $57.2K366,159SEC↗
Banerjee SubhashisChief Medical Officer S Sale2026-10-052026-10-061,099$6.84 $7.5K169,848SEC↗
Aslan FredChief Executive Officer, Dir S Sale2026-10-052026-10-0661,696$6.84 $421.8K1,543,069SEC↗
Aslan FredChief Executive Officer A Award deriv2026-09-152026-09-15315,000— $0315,000SEC↗
Aslan FredChief Executive Officer A Award2026-09-152026-09-15110,000— $01,604,765SEC↗
Aslan FredChief Executive Officer, Dir A Award deriv2026-09-152026-09-15315,000— $0315,000SEC↗
Aslan FredChief Executive Officer, Dir A Award2026-09-152026-09-15110,000— $01,604,765SEC↗
MOORE ALISONDirector A Award deriv2026-09-102026-09-1416,250— $016,250SEC↗
Baker Daniel G.Director A Award deriv2026-09-102026-09-1416,250— $016,250SEC↗
DANIELS BRIANDirector A Award deriv2026-09-102026-09-1416,250— $016,250SEC↗
HOUGEN ELIZABETH LDirector A Award deriv2026-09-102026-09-1416,250— $016,250SEC↗
Sorg Elaine K.Director A Award deriv2026-09-102026-09-1416,250— $016,250SEC↗
Stoppel LauraDirector A Award deriv2026-09-102026-09-1416,250— $016,250SEC↗
Kolchinsky PeterDirector, 10% Owner A Award deriv2026-09-102026-09-1416,250— $016,250SEC↗
Aslan FredChief Executive Officer A Award deriv2026-09-102026-09-14155,000— $0155,000SEC↗
Aslan FredChief Executive Officer A Award2026-09-102026-09-1445,000— $01,494,765SEC↗
RA CAPITAL MANAGEMENT, L.P.Director, 10% Owner A Award deriv2026-09-102026-09-1416,250— $016,250SEC↗
Aslan FredChief Executive Officer, Dir A Award deriv2026-09-102026-09-14155,000— $0155,000SEC↗
Aslan FredChief Executive Officer, Dir A Award2026-09-102026-09-1445,000— $01,494,765SEC↗
Stoppel LauraDirector A Award deriv2026-09-102026-09-1416,250— $016,250SEC↗
Sorg Elaine K.Director A Award deriv2026-09-102026-09-1416,250— $016,250SEC↗
HOUGEN ELIZABETH LDirector A Award deriv2026-09-102026-09-1416,250— $016,250SEC↗
DANIELS BRIANDirector A Award deriv2026-09-102026-09-1416,250— $016,250SEC↗
Baker Daniel G.Director A Award deriv2026-09-102026-09-1416,250— $016,250SEC↗
MOORE ALISONDirector A Award deriv2026-09-102026-09-1416,250— $016,250SEC↗
Banerjee SubhashisChief Medical Officer A Award deriv2026-09-092026-09-1185,000— $085,000SEC↗
Bush JenniferCOO, CLO, Compliance Officer A Award deriv2026-09-092026-09-11135,000— $0135,000SEC↗
Horan ChristopherChief Tech Operations Office A Award deriv2026-09-092026-09-11120,000— $0120,000SEC↗
Miralles Gines DiegoPresident & Head of R&D A Award deriv2026-09-092026-09-11135,000— $0135,000SEC↗
Banerjee SubhashisChief Medical Officer A Award2026-09-092026-09-1130,000— $0170,947SEC↗
Bush JenniferCOO, CLO, Compliance Officer A Award2026-09-092026-09-1145,000— $0374,529SEC↗
Horan ChristopherChief Tech Operations Office A Award2026-09-092026-09-1140,000— $0323,084SEC↗
Miralles Gines DiegoPresident & Head of R&D A Award2026-09-092026-09-1145,000— $0122,500SEC↗
Miralles Gines DiegoPresident & Head of R&D A Award deriv2026-09-092026-09-11135,000— $0135,000SEC↗
Miralles Gines DiegoPresident & Head of R&D A Award2026-09-092026-09-1145,000— $0122,500SEC↗
Horan ChristopherChief Tech Operations Office A Award deriv2026-09-092026-09-11120,000— $0120,000SEC↗
Horan ChristopherChief Tech Operations Office A Award2026-09-092026-09-1140,000— $0323,084SEC↗
Bush JenniferCOO, CLO, Compliance Officer A Award deriv2026-09-092026-09-11135,000— $0135,000SEC↗
Bush JenniferCOO, CLO, Compliance Officer A Award2026-09-092026-09-1145,000— $0374,529SEC↗
Banerjee SubhashisChief Medical Officer A Award deriv2026-09-092026-09-1185,000— $085,000SEC↗
Banerjee SubhashisChief Medical Officer A Award2026-09-092026-09-1130,000— $0170,947SEC↗
MOORE ALISONDirector A Award deriv2026-09-082026-09-0813,750— $013,750SEC↗
Baker Daniel G.Director A Award deriv2026-09-082026-09-0813,750— $013,750SEC↗
DANIELS BRIANDirector A Award deriv2026-09-082026-09-0813,750— $013,750SEC↗
HOUGEN ELIZABETH LDirector A Award deriv2026-09-082026-09-0813,750— $013,750SEC↗
Sorg Elaine K.Director A Award deriv2026-09-082026-09-0813,750— $013,750SEC↗
Stoppel LauraDirector A Award deriv2026-09-082026-09-0813,750— $013,750SEC↗
Kolchinsky PeterDirector, 10% Owner A Award deriv2026-09-082026-09-0813,750— $013,750SEC↗
Aslan FredChief Executive Officer S Sale2026-09-082026-09-0923,429$10.92 $255.8K1,449,765SEC↗
RA CAPITAL MANAGEMENT, L.P.Director, 10% Owner A Award deriv2026-09-082026-09-0813,750— $013,750SEC↗
Stoppel LauraDirector A Award deriv2026-09-082026-09-0813,750— $013,750SEC↗
Sorg Elaine K.Director A Award deriv2026-09-082026-09-0813,750— $013,750SEC↗
HOUGEN ELIZABETH LDirector A Award deriv2026-09-082026-09-0813,750— $013,750SEC↗
DANIELS BRIANDirector A Award deriv2026-09-082026-09-0813,750— $013,750SEC↗
Baker Daniel G.Director A Award deriv2026-09-082026-09-0813,750— $013,750SEC↗
MOORE ALISONDirector A Award deriv2026-09-082026-09-0813,750— $013,750SEC↗
Aslan FredChief Executive Officer, Dir S Sale2026-09-082026-09-0923,429$10.92 $255.7K1,449,765SEC↗
Aslan FredChief Executive Officer S Sale2026-09-032026-09-0461,888$11.16 $690.7K1,473,194SEC↗
Banerjee SubhashisChief Medical Officer S Sale2026-09-032026-09-041,100$11.16 $12.3K140,947SEC↗
Bush JenniferCOO, CLO, Compliance Officer S Sale2026-09-032026-09-048,391$11.16 $93.6K329,529SEC↗
Horan ChristopherChief Tech Operations Office S Sale2026-09-032026-09-0410,366$11.16 $115.7K283,084SEC↗
Horan ChristopherChief Tech Operations Office S Sale2026-09-032026-09-0410,366$11.16 $115.6K283,084SEC↗
Bush JenniferCOO, CLO, Compliance Officer S Sale2026-09-032026-09-048,391$11.16 $93.6K329,529SEC↗
Banerjee SubhashisChief Medical Officer S Sale2026-09-032026-09-041,100$11.16 $12.3K140,947SEC↗
Aslan FredChief Executive Officer, Dir S Sale2026-09-032026-09-0461,888$11.16 $690.4K1,473,194SEC↗
Banerjee SubhashisChief Medical Officer M Exercise deriv2026-08-272026-08-315,306— $074,265SEC↗
Banerjee SubhashisChief Medical Officer S Sale2026-08-272026-08-318,222$12.01 $98.7K142,047SEC↗
Banerjee SubhashisChief Medical Officer M Exercise2026-08-272026-08-315,306$1.92 $10.2K150,269SEC↗
Banerjee SubhashisChief Medical Officer M Exercise deriv2026-08-272026-08-315,306— $074,265SEC↗
Banerjee SubhashisChief Medical Officer S Sale2026-08-272026-08-318,222$12.01 $98.7K142,047SEC↗
Banerjee SubhashisChief Medical Officer M Exercise2026-08-272026-08-315,306$1.92 $10.2K150,269SEC↗
Banerjee SubhashisChief Medical Officer M Exercise deriv2026-08-182026-08-19429— $079,571SEC↗
Banerjee SubhashisChief Medical Officer M Exercise2026-08-182026-08-19429$1.92 $824145,392SEC↗
Banerjee SubhashisChief Medical Officer S Sale2026-08-182026-08-19429$12.00 $5.1K144,963SEC↗
Banerjee SubhashisChief Medical Officer M Exercise deriv2026-08-182026-08-19429— $079,571SEC↗
Banerjee SubhashisChief Medical Officer S Sale2026-08-182026-08-19429$12.00 $5.1K144,963SEC↗
Banerjee SubhashisChief Medical Officer M Exercise2026-08-182026-08-19429$1.92 $824145,392SEC↗
RA Capital Healthcare Fund LPDirector, 10% Owner P Buy2026-07-312026-07-3124,944$9.93 $247.7K17,329,570SEC↗
RA CAPITAL MANAGEMENT, L.P.Director, 10% Owner P Buy2026-07-312026-07-3124,944$9.93 $247.7K17,329,570SEC↗
RA Capital Healthcare Fund LPDirector, 10% Owner P Buy2026-07-292026-07-3120,824$9.99 $208.0K17,304,626SEC↗
RA CAPITAL MANAGEMENT, L.P.Director, 10% Owner P Buy2026-07-292026-07-3120,824$9.99 $208.0K17,304,626SEC↗
RA Capital Nexus Fund III, L.PDirector P Buy2026-07-242026-07-2841,319$9.99 $412.8K17,283,802SEC↗
RA CAPITAL MANAGEMENT, L.P.Director, 10% Owner P Buy2026-07-242026-07-2841,319$9.99 $412.8K17,283,802SEC↗
Kolchinsky PeterDirector, 10% Owner P Buy2026-07-232026-07-2359,880$9.96 $596.4K17,242,483SEC↗
Kolchinsky PeterDirector, 10% Owner P Buy2026-07-222026-07-2384,124$9.93 $835.4K17,182,603SEC↗
Kolchinsky PeterDirector, 10% Owner P Buy2026-07-212026-07-23120,582$9.55 $1.15M17,098,479SEC↗
RA Capital Healthcare Fund LPDirector, 10% Owner P Buy2026-07-172026-07-207,882$8.95 $70.5K16,977,927SEC↗
RA Capital Healthcare Fund LPDirector, 10% Owner P Buy2026-07-162026-07-20152,472$8.93 $1.36M16,970,045SEC↗
Shah Rajeev M.Director, 10% Owner P Buy2026-07-132026-07-146,552$8.94 $58.6K16,817,573SEC↗
RA Capital Nexus Fund, L.P.Director P Buy2026-07-132026-07-236,522$8.94 $58.3K16,817,543SEC↗
Shah Rajeev M.Director, 10% Owner P Buy2026-07-102026-07-1415,102$8.97 $135.5K16,811,021SEC↗
RA CAPITAL MANAGEMENT, L.P.Director, 10% Owner P Buy2026-06-262026-06-291,876$8.98 $16.8K16,795,919SEC↗
RA CAPITAL MANAGEMENT, L.P.Director, 10% Owner P Buy2026-06-252026-06-2931,000$8.88 $275.3K16,794,043SEC↗
Kolchinsky PeterDirector, 10% Owner P Buy2026-06-162026-06-16124,893$8.89 $1.11M16,763,043SEC↗
Kolchinsky PeterDirector, 10% Owner P Buy2026-06-152026-06-1615,414$8.99 $138.6K16,638,150SEC↗
Kolchinsky PeterDirector, 10% Owner P Buy2026-06-122026-06-16391,019$8.57 $3.35M16,622,736SEC↗
RA Capital Nexus Fund, L.P.Director P Buy2026-06-112026-06-11548,580$7.91 $4.34M16,231,717SEC↗
RA Capital Nexus Fund, L.P.Director P Buy2026-06-102026-06-11103$7.00 $72115,683,137SEC↗
RA Capital Nexus Fund, L.P.Director P Buy2026-06-092026-06-11479,039$6.91 $3.31M15,683,034SEC↗
Aslan FredChief Executive Officer S Sale2026-05-192026-05-1927,116$9.01 $244.3K1,535,082SEC↗
Banerjee SubhashisChief Medical Officer S Sale2026-05-192026-05-197,037$9.01 $63.4K144,963SEC↗
Bush JenniferCOO, CLO, Compliance Officer S Sale2026-05-192026-05-198,790$9.01 $79.2K337,920SEC↗
Horan ChristopherChief Tech Operations Office S Sale2026-05-192026-05-197,002$9.01 $63.1K293,450SEC↗
Raymon HeatherSVP, Research and Developmen S Sale2026-05-192026-05-193,095$9.01 $27.9K148,228SEC↗
Miralles Gines DiegoPresident & Head of R&D A Award deriv2026-05-182026-05-19232,500— $0232,500SEC↗
Miralles Gines DiegoPresident & Head of R&D A Award2026-05-182026-05-1977,500— $077,500SEC↗
RA Capital Nexus Fund III, L.PDirector P Buy deriv2026-05-112026-05-132,170,138$11.52 $25.00M2,170,138SEC↗
RA Capital Nexus Fund III, L.PDirector P Buy2026-05-112026-05-136,510,416$11.52 $75.00M15,203,995SEC↗
GC Corp.10% Owner P Buy2026-05-112026-05-28347,222$11.52 $4.00M1,607,734SEC↗
GC Corp.10% Owner P Buy2026-05-112026-05-281,085,069$11.52 $12.50M4,391,969SEC↗
Huston Thad AllenChief Financial Officer A Award2026-03-102026-03-10220,000— $0220,000SEC↗
Sorg Elaine K.Director A Award deriv2026-02-182026-02-1927,500— $027,500SEC↗
Aslan FredPresident and CEO A Award2026-02-152026-02-18366,850— $01,576,798SEC↗
Aslan FredPresident and CEO F Tax w/h2026-02-152026-02-1814,600$4.00 $58.4K1,562,198SEC↗
Banerjee SubhashisChief Medical Officer A Award2026-02-152026-02-18102,000— $0152,000SEC↗
Bush JenniferCOO, CLO, Secy, Compliance O F Tax w/h2026-02-152026-02-183,515$4.00 $14.1K346,710SEC↗
Bush JenniferCOO, CLO, Secy, Compliance O A Award2026-02-152026-02-18117,300— $0350,225SEC↗
Horan ChristopherChief Tech Operations Office A Award2026-02-152026-02-18117,300— $0302,639SEC↗
Horan ChristopherChief Tech Operations Office F Tax w/h2026-02-152026-02-182,187$4.00 $8.7K300,452SEC↗
Raymon HeatherSVP, Research and Developmen F Tax w/h2026-02-152026-02-181,521$4.00 $6.1K151,323SEC↗
Raymon HeatherSVP, Research and Developmen A Award2026-02-152026-02-1846,000— $0152,844SEC↗
Aslan FredPresident and CEO S Sale2025-12-152025-12-153,187$6.00 $19.1K1,209,948SEC↗
Aslan FredPresident and CEO D To issuer deriv2025-12-122025-12-12100,577— $00SEC↗
Aslan FredPresident and CEO D To issuer deriv2025-12-122025-12-12319,331— $00SEC↗
Aslan FredPresident and CEO D To issuer deriv2025-12-122025-12-12113,999— $00SEC↗
Aslan FredPresident and CEO D To issuer deriv2025-12-122025-12-1226,450— $00SEC↗
Aslan FredPresident and CEO D To issuer deriv2025-12-122025-12-12257,319— $00SEC↗
Aslan FredPresident and CEO D To issuer deriv2025-12-122025-12-1251,463— $00SEC↗
Bush JenniferCOO, CLO, Secy, Compliance O D To issuer deriv2025-12-122025-12-1241,039— $00SEC↗
Bush JenniferCOO, CLO, Secy, Compliance O D To issuer deriv2025-12-122025-12-1214,202— $00SEC↗
Bush JenniferCOO, CLO, Secy, Compliance O D To issuer deriv2025-12-122025-12-129,119— $00SEC↗
Bush JenniferCOO, CLO, Secy, Compliance O D To issuer deriv2025-12-122025-12-1220,519— $00SEC↗
Horan ChristopherChief Tech Operations Office D To issuer deriv2025-12-122025-12-1220,519— $00SEC↗
Horan ChristopherChief Tech Operations Office D To issuer deriv2025-12-122025-12-129,119— $00SEC↗
Horan ChristopherChief Tech Operations Office D To issuer deriv2025-12-122025-12-1277,519— $00SEC↗
Raymon HeatherSVP, Research and Developmen D To issuer deriv2025-12-122025-12-1210,259— $00SEC↗
Raymon HeatherSVP, Research and Developmen D To issuer deriv2025-12-122025-12-1218,239— $00SEC↗
Raymon HeatherSVP, Research and Developmen D To issuer deriv2025-12-122025-12-1211,399— $00SEC↗
Raymon HeatherSVP, Research and Developmen D To issuer deriv2025-12-122025-12-1212,539— $00SEC↗
Raymon HeatherSVP, Research and Developmen D To issuer deriv2025-12-122025-12-1214,819— $00SEC↗
Aslan FredPresident and CEO A Award2025-12-122025-12-12869,136— $01,213,135SEC↗
Bush JenniferCOO, CLO, Secy, Compliance O A Award2025-12-122025-12-1284,877— $0232,925SEC↗
Horan ChristopherChief Tech Operations Office A Award2025-12-122025-12-12107,156— $0185,339SEC↗
Raymon HeatherSVP, Research and Developmen A Award2025-12-122025-12-1267,253— $0106,844SEC↗
Aslan FredPresident and CEO S Sale2025-11-172025-11-176,375$3.38 $21.5K343,999SEC↗
Aslan FredPresident and CEO F Tax w/h2025-11-152025-11-176,347$3.25 $20.6K350,374SEC↗
Krishnamohan NehaChief Financial Officer F Tax w/h2025-11-152025-11-173,490$3.25 $11.3K99,356SEC↗
Bush JenniferCOO, CLO, Secy, Compliance O F Tax w/h2025-11-152025-11-173,055$3.25 $9.9K148,048SEC↗
Horan ChristopherChief Tech Operations Office F Tax w/h2025-11-152025-11-171,899$3.25 $6.2K78,183SEC↗
Raymon HeatherSVP, Research and Developmen F Tax w/h2025-11-152025-11-171,375$3.25 $4.5K39,591SEC↗
Aslan FredPresident and CEO S Sale2025-10-172025-10-1725,500$6.00 $153.0K356,721SEC↗
Horan ChristopherChief Tech Operations Office F Tax w/h2025-08-152025-08-183,577$2.75 $9.8K80,082SEC↗
Bush JenniferCOO, CLO, Secy, Compliance O F Tax w/h2025-08-152025-08-186,409$2.75 $17.6K151,103SEC↗
Krishnamohan NehaChief Financial Officer F Tax w/h2025-08-152025-08-185,813$2.75 $16.0K102,846SEC↗
Raymon HeatherSVP, Research and Developmen F Tax w/h2025-08-152025-08-181,639$2.75 $4.5K40,966SEC↗
Aslan FredPresident and CEO F Tax w/h2025-08-152025-08-184,472$2.75 $12.3K382,221SEC↗
Aslan FredPresident and CEO S Sale2025-08-152025-08-1825,500$2.73 $69.6K386,693SEC↗
DANIELS BRIANDirector A Award deriv2025-06-242025-06-2613,750— $013,750SEC↗
Miralles Gines DiegoDirector A Award deriv2025-06-242025-06-2613,750— $013,750SEC↗
HOUGEN ELIZABETH LDirector A Award deriv2025-06-242025-06-2613,750— $013,750SEC↗
Baker Daniel G.Director A Award deriv2025-06-242025-06-2613,750— $013,750SEC↗
MOORE ALISONDirector A Award deriv2025-06-242025-06-2613,750— $013,750SEC↗
Stoppel LauraDirector A Award deriv2025-06-242025-06-2613,750— $013,750SEC↗
RA CAPITAL MANAGEMENT, L.P.Director, 10% Owner A Award deriv2025-06-242025-06-2613,750— $013,750SEC↗
Horan ChristopherChief Tech Operations Office F Tax w/h2025-05-152025-08-181,341$2.13 $2.9K83,659SEC↗
Bush JenniferCOO, CLO, Secy, Compliance O F Tax w/h2025-05-152025-08-181,937$2.13 $4.1K157,512SEC↗
Krishnamohan NehaChief Financial Officer F Tax w/h2025-05-152025-08-181,341$2.13 $2.9K108,659SEC↗
Raymon HeatherSVP, Research and Developmen F Tax w/h2025-05-152025-08-18745$2.13 $1.6K42,605SEC↗
Aslan FredPresident and CEO F Tax w/h2025-05-152025-08-184,472$2.13 $9.5K412,193SEC↗
Banerjee SubhashisChief Medical Officer A Award deriv2025-04-082025-04-2580,000— $080,000SEC↗
Banerjee SubhashisChief Medical Officer A Award2025-04-082025-04-2550,000— $050,000SEC↗
Aslan FredPresident and CEO A Award2025-03-052025-03-07200,000— $0416,665SEC↗
Bush JenniferCOO, CLO, Secy, Compliance O A Award2025-02-262025-02-2886,650— $0159,449SEC↗
Krishnamohan NehaChief Financial Officer A Award2025-02-262025-02-2860,000— $0110,000SEC↗
Horan ChristopherChief Tech Operations Office A Award2025-02-262025-02-2860,000— $085,000SEC↗
Graef ThorstenChief Medical Officer A Award2025-02-262025-02-2860,000— $080,000SEC↗
Raymon HeatherSVP, Research and Developmen A Award2025-02-262025-02-2833,350— $043,350SEC↗
Baker Daniel G.Director A Award deriv2025-01-282025-01-2927,500— $027,500SEC↗
MOORE ALISONDirector A Award deriv2024-10-212024-10-2227,500— $027,500SEC↗
Bush JenniferCOO, CLO, Secy, Compliance O A Award2024-09-122024-09-1350,000— $072,799SEC↗
Krishnamohan NehaChief Financial Officer A Award2024-09-122024-09-1350,000— $050,000SEC↗
Horan ChristopherChief Tech Operations Office A Award2024-09-122024-09-1325,000— $025,000SEC↗
Graef ThorstenChief Medical Officer A Award2024-09-122024-09-1320,000— $020,000SEC↗
Raymon HeatherSVP, Research and Developmen A Award2024-09-122024-09-1310,000— $010,000SEC↗
Huh Yong-JunDirector C Conversion deriv2024-07-222024-07-2262,181— $00SEC↗
Huh Yong-JunDirector C Conversion deriv2024-07-222024-07-22292,791— $00SEC↗
Huh Yong-JunDirector C Conversion deriv2024-07-222024-07-22330,095— $00SEC↗
Huh Yong-JunDirector C Conversion deriv2024-07-222024-07-22667,185— $00SEC↗
GC Cell Corp10% Owner C Conversion deriv2024-07-222024-07-22330,095— $00SEC↗
GC Cell Corp10% Owner C Conversion deriv2024-07-222024-07-22667,185— $00SEC↗
GC Cell Corp10% Owner C Conversion deriv2024-07-222024-07-22292,791— $00SEC↗
GC Cell Corp10% Owner C Conversion deriv2024-07-222024-07-2262,181— $00SEC↗
VENBIO GLOBAL STRATEGIC GP III10% Owner C Conversion deriv2024-07-222024-07-22214,692— $00SEC↗
VENBIO GLOBAL STRATEGIC GP III10% Owner C Conversion deriv2024-07-222024-07-22843,592— $00SEC↗
Wellington Biomedical Innovati10% Owner C Conversion deriv2024-07-222024-07-22145,089— $00SEC↗
5AM Partners VI, LLC10% Owner C Conversion deriv2024-07-222024-07-24843,592— $00SEC↗
5AM Partners VI, LLC10% Owner C Conversion deriv2024-07-222024-07-24214,692— $00SEC↗
Kolchinsky PeterDirector, 10% Owner C Conversion deriv2024-07-222024-07-2468,320— $00SEC↗
Kolchinsky PeterDirector, 10% Owner C Conversion deriv2024-07-222024-07-24210,898— $00SEC↗
Kolchinsky PeterDirector, 10% Owner C Conversion deriv2024-07-222024-07-2453,673— $00SEC↗
Kolchinsky PeterDirector, 10% Owner C Conversion deriv2024-07-222024-07-24161,019— $00SEC↗
Kolchinsky PeterDirector, 10% Owner C Conversion deriv2024-07-222024-07-24564,372— $00SEC↗
Aslan FredPresident and CEO A Award2024-07-222024-07-22228,905— $0228,905SEC↗
Huh Yong-JunDirector C Conversion2024-07-222024-07-2262,181— $0587,530SEC↗
Huh Yong-JunDirector C Conversion2024-07-222024-07-22292,791— $0525,349SEC↗
Huh Yong-JunDirector P Buy2024-07-222024-07-221,666,666$12.00 $20.00M3,306,900SEC↗
Huh Yong-JunDirector C Conversion2024-07-222024-07-22667,185— $01,016,022SEC↗
Huh Yong-JunDirector C Conversion2024-07-222024-07-22330,095— $01,346,117SEC↗
Huh Yong-JunDirector J Other2024-07-222024-07-22294,117$10.20 $3.00M1,640,234SEC↗
Huh Yong-JunDirector P Buy2024-07-222024-07-22416,666$12.00 $5.00M1,260,512SEC↗
Huh Yong-JunDirector J Other2024-07-222024-07-22256,316$10.20 $2.61M843,846SEC↗
GC Cell Corp10% Owner C Conversion2024-07-222024-07-22667,185— $01,016,022SEC↗
GC Cell Corp10% Owner C Conversion2024-07-222024-07-22330,095— $01,346,117SEC↗
GC Cell Corp10% Owner J Other2024-07-222024-07-22294,117$10.20 $3.00M1,640,234SEC↗
GC Cell Corp10% Owner P Buy2024-07-222024-07-221,666,666$12.00 $20.00M3,306,900SEC↗
GC Cell Corp10% Owner C Conversion2024-07-222024-07-22292,791— $0525,349SEC↗
GC Cell Corp10% Owner C Conversion2024-07-222024-07-2262,181— $0587,530SEC↗
GC Cell Corp10% Owner J Other2024-07-222024-07-22256,316$10.20 $2.61M843,846SEC↗
GC Cell Corp10% Owner P Buy2024-07-222024-07-22416,666$12.00 $5.00M1,260,512SEC↗
VENBIO GLOBAL STRATEGIC GP III10% Owner C Conversion2024-07-222024-07-22214,692— $01,058,284SEC↗
VENBIO GLOBAL STRATEGIC GP III10% Owner P Buy2024-07-222024-07-22416,666$12.00 $5.00M1,936,637SEC↗
VENBIO GLOBAL STRATEGIC GP III10% Owner J Other2024-07-222024-07-22461,687— $01,519,971SEC↗
VENBIO GLOBAL STRATEGIC GP III10% Owner C Conversion2024-07-222024-07-22843,592— $0843,592SEC↗
Wellington Biomedical Innovati10% Owner C Conversion2024-07-222024-07-22145,089— $0145,089SEC↗
Wellington Biomedical Innovati10% Owner J Other2024-07-222024-07-2249,019$10.20 $500.0K194,108SEC↗
5AM Partners VI, LLC10% Owner P Buy2024-07-222024-07-24833,333$12.00 $10.00M1,182,054SEC↗
5AM Partners VI, LLC10% Owner C Conversion2024-07-222024-07-241,058,284— $01,058,284SEC↗
5AM Partners VI, LLC10% Owner J Other2024-07-222024-07-24112,966$10.20 $1.15M1,171,250SEC↗
5AM Partners VI, LLC10% Owner J Other2024-07-222024-07-24348,721$10.20 $3.56M348,721SEC↗
Kolchinsky PeterDirector, 10% Owner J Other2024-07-222024-07-24323,181$10.20 $3.30M1,048,572SEC↗
Kolchinsky PeterDirector, 10% Owner C Conversion2024-07-222024-07-24725,391— $0725,391SEC↗
Kolchinsky PeterDirector, 10% Owner C Conversion2024-07-222024-07-24264,571— $0264,571SEC↗
Kolchinsky PeterDirector, 10% Owner P Buy2024-07-222024-07-24688,326$12.00 $8.26M826,832SEC↗
Kolchinsky PeterDirector, 10% Owner P Buy2024-07-222024-07-247,645,007$12.00 $91.74M8,693,579SEC↗
Kolchinsky PeterDirector, 10% Owner J Other2024-07-222024-07-24138,506$10.20 $1.41M138,506SEC↗
Kolchinsky PeterDirector, 10% Owner C Conversion2024-07-222024-07-2468,320— $068,320SEC↗
Aslan FredPresident and CEO A Award deriv2024-07-182024-07-22343,811— $0343,811SEC↗